- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Med Life SA (ROM)
Med Life SA stock price live, this page displays BX ROM stock exchange data. View the ROM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Med Life SA real time stock price chart below.
What Is the Med Life SA Stock Price Today?
The Med Life SA stock price today is 10.10.
What Is the Stock Symbol for Med Life SA?
The stock symbol for Med Life SA is "ROM."
What Stock Exchange Does Med Life SA Trade On?
Med Life SA is listed and trades on the Bucharest stock exchange.
Is Med Life SA a Good Stock to Buy?
Determining whether Med Life SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ROM quote. (ISIN: ROMEDLACNOR6)
What Is the Med Life SA Stock Price Today?
The Med Life SA stock price today is 10.10.
What Is the Stock Symbol for Med Life SA?
The stock symbol for Med Life SA is "ROM."
What Stock Exchange Does Med Life SA Trade On?
Med Life SA is listed and trades on the Bucharest stock exchange.
Is Med Life SA a Good Stock to Buy?
Determining whether Med Life SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ROM quote. (ISIN: ROMEDLACNOR6)
Bucharest
Currency in RON
10.10
-0.08(-0.79%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.10
10.32
52 wk Range
8.18
14.46
Earnings results expected in 13 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.1010.32
52 wk Range
8.1814.46
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
ROM Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
11.79
Upside
+16.77%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Healthcare Providers & Services industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Analyst Ratings
0 Buy
5 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 11.79
(+16.77% Upside)
Med Life SA Earnings Call Summary for Q2/2026
- MedLife reported H1 2026 pro forma revenue up 11% to RON 1.7B and EBITDA up 14.5% to RON 259M, driven by 9.5% organic growth across network.
- Leu depreciation of 2.8% vs euro generated RON 56M unrealized FX loss, resulting in pro forma net loss of RON 20M despite strong operational performance.
- Management reaffirmed FY 2026 targets of RON 512M EBITDA with H2 margin goal of 15.1%; no price increases planned, focusing on volume growth instead.
- Net debt-to-EBITDA stood at 3.85x in June; company targets 3.5x by year-end through deleveraging and plans to mitigate FX risk via local financing.
- Shares fell 0.7% to $11.3 post-results despite 58% YTD gain; investors weighed strong margins against elevated leverage and currency headwinds.
Last Updated: 08/28/2026, 10:04 PM
Read Full TranscriptEarnings
Latest Release
Aug 28, 2026
EPS / Forecast
-0.07 / --
Revenue / Forecast
885.8M / --
Compare ROM to Peers and Sector
Metrics to compare | ROM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipROMPeersSector | |
|---|---|---|---|---|
P/E Ratio | −386.8x | 4.8x | −0.2x | |
PEG Ratio | 0.48 | 0.31 | 0.00 | |
Price/Book | 11.8x | 1.1x | 2.6x | |
Price / LTM Sales | 1.6x | 0.6x | 2.8x | |
Upside (Analyst Target) | 16.8% | 24.5% | 65.6% | |
Fair Value Upside | Unlock | 27.1% | 10.0% | Unlock |
Med Life S.A., a private healthcare provider, provides integrated medical services through its clinics and hospitals in Romania. The company offers outpatient units and diagnostic imaging services; consultations with general practitioners and specialists; diagnostic imaging tests; day hospitalization services; hospitalization and surgical treatment services; medical and surgical specialties; maternal and child health dedicated services; and stem cell bank. It also provides laboratory services, such as biochemistry, pathological anatomy, molecular biology and genetics, hematology, immunology, microbiology, cytology, and toxicology; healthcare packages; a range of dental services; and fitness services and wellness facilities through the Sweat Concept network and Sanopass platform. In addition, the company is involved in the development of building projects; insurance broker; rental activities; and distribution and retail sale of pharmaceutical products in specialized stores. Med Life S.A. was incorporated in 1996 and is headquartered in Bucharest, Romania.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Med Life (ROM) Stock Price Today?
The Med Life stock price today is 10.10 RON.
What Stock Exchange Does Med Life Trade On?
Med Life is listed and trades on the Bucharest Stock Exchange.
What Is the Stock Symbol for Med Life?
The stock symbol for Med Life is "ROM."
What Is the Med Life Market Cap?
As of today, Med Life market cap is 5.36B RON.
What Is Med Life's Earnings Per Share (TTM)?
The Med Life EPS (TTM) is -0.026.
When Is the Next Med Life Earnings Date?
Med Life will release its next earnings report on Nov 20, 2026.
From a Technical Analysis Perspective, Is ROM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Med Life Stock Split?
Med Life has split 2 times.
How Many Employees Does Med Life Have?
Med Life has 6744 employees.
What is the current trading status of Med Life (ROM)?
As of Nov 07, 2026, Med Life (ROM) is trading at a price of 10.10 RON, with a previous close of 5.89 RON. The stock has fluctuated within a day range of 10.10 RON to 10.32 RON, while its 52-week range spans from 8.18 RON to 14.46 RON.
What Is Med Life (ROM) Price Target According to Analysts?
The average 12-month price target for Med Life is 11.79 RON, with a high estimate of 12.5 RON and a low estimate of 11 RON. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +16.77% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.